Greater Financial Statements From 2010 to 2024
| GCAN Stock | USD 0.0004 0.0001 20.00% |
Check Greater Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Greater Cannabis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Greater financial statements analysis is a perfect complement when working with Greater Cannabis Valuation or Volatility modules.
Greater |
Greater Cannabis Company Shares Outstanding Analysis
Greater Cannabis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Greater Cannabis Shares Outstanding | 668.64 M |
Most of Greater Cannabis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greater Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Greater Cannabis has 668.64 M of shares currently outstending. This is 270.37% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 16.93% lower than that of the firm.
Greater Cannabis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Greater Cannabis's current stock value. Our valuation model uses many indicators to compare Greater Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Greater Cannabis competition to find correlations between indicators driving Greater Cannabis's intrinsic value. More Info.Greater Cannabis is rated # 4 in return on asset category among its peers. It is rated # 5 in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Greater Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Greater Cannabis' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Greater Cannabis Financial Statements
Greater Cannabis investors utilize fundamental indicators, such as revenue or net income, to predict how Greater Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. The company was founded in 2014 and is based in Baltimore, Maryland. Greater Cannabis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Pair Trading with Greater Cannabis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greater Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greater Cannabis will appreciate offsetting losses from the drop in the long position's value.Moving against Greater Pink Sheet
| 0.71 | SSNLF | Samsung Electronics | PairCorr |
| 0.66 | PTAIF | PT Astra International | PairCorr |
| 0.4 | TLKMF | Telkom Indonesia Tbk | PairCorr |
The ability to find closely correlated positions to Greater Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greater Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greater Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greater Cannabis to buy it.
The correlation of Greater Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greater Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greater Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greater Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Greater Pink Sheet
Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.